Reduced efficacy of the Plk1 inhibitor BI 2536 on the progression of hepatocellular carcinoma due to low intratumoral drug levels
由于肿瘤内药物浓度低，Plk1抑制剂BI 2536对肝细胞癌进展的疗效降低。
期刊:Neoplasia
影响因子:7.7
doi:10.1596/neo.111366
Haupenthal, Jörg; Bihrer, Verena; Korkusuz, Huedayi; Kollmar, Otto; Schmithals, Christian; Kriener, Susanne; Engels, Knut; Pleli, Thomas; Benz, Alexander; Canamero, Marta; Longerich, Thomas; Kronenberger, Bernd; Richter, Swantje; Waidmann, Oliver; Vogl, Thomas J; Zeuzem, Stefan; Piiper, Albrecht
